BIODISPONIBILITA DI UN PREPARATO RITARDO DI AMINOFILLINA

Translated title of the contribution: Bioavailability of a slow absorption aminophylline product

Research output: Contribution to journalArticle

Abstract

Absorption of theophylline from one commercial product labelled as aminophylline systained release was compared to the absorption from an oral solution of aminophylline in a single-dose bioavailability study. Aminomal-R tablets had a bioavailability (101.2 ± 19) statistically indistinguishable from that of the standard but showed significantly slower absorption (peak times of 3.6 ± 1.1 h vs 1.3 ± 0.8 h) and lower peak plasma concentrations (16.8 ± 4.7 mg/l/l g aminoph. dose vs 21.1 ± 4.2 mg/l/l g aminoph. dose). Projections of plasma concentrations upon multiple dosing were made from single dose data: the dosage interval (every 12 h) concentration ratio which reflects both the frequency of dosing and the entry of the drug into and removal from the body was 1.8 vs 3.1.

Original languageItalian
Pages (from-to)641-645
Number of pages5
JournalMinerva Medica
Volume76
Issue number13
Publication statusPublished - 1985

Fingerprint

Aminophylline
Biological Availability
Theophylline
Tablets
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

BIODISPONIBILITA DI UN PREPARATO RITARDO DI AMINOFILLINA. / Regazzi, M. B.; Guarnone, E.; Bartoli, A.

In: Minerva Medica, Vol. 76, No. 13, 1985, p. 641-645.

Research output: Contribution to journalArticle

@article{32ad70acc1d144b691e7990f1e805e26,
title = "BIODISPONIBILITA DI UN PREPARATO RITARDO DI AMINOFILLINA",
abstract = "Absorption of theophylline from one commercial product labelled as aminophylline systained release was compared to the absorption from an oral solution of aminophylline in a single-dose bioavailability study. Aminomal-R tablets had a bioavailability (101.2 ± 19) statistically indistinguishable from that of the standard but showed significantly slower absorption (peak times of 3.6 ± 1.1 h vs 1.3 ± 0.8 h) and lower peak plasma concentrations (16.8 ± 4.7 mg/l/l g aminoph. dose vs 21.1 ± 4.2 mg/l/l g aminoph. dose). Projections of plasma concentrations upon multiple dosing were made from single dose data: the dosage interval (every 12 h) concentration ratio which reflects both the frequency of dosing and the entry of the drug into and removal from the body was 1.8 vs 3.1.",
author = "Regazzi, {M. B.} and E. Guarnone and A. Bartoli",
year = "1985",
language = "Italian",
volume = "76",
pages = "641--645",
journal = "Minerva Medicolegale e Archivio di Antropologia Criminale",
issn = "0026-4806",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "13",

}

TY - JOUR

T1 - BIODISPONIBILITA DI UN PREPARATO RITARDO DI AMINOFILLINA

AU - Regazzi, M. B.

AU - Guarnone, E.

AU - Bartoli, A.

PY - 1985

Y1 - 1985

N2 - Absorption of theophylline from one commercial product labelled as aminophylline systained release was compared to the absorption from an oral solution of aminophylline in a single-dose bioavailability study. Aminomal-R tablets had a bioavailability (101.2 ± 19) statistically indistinguishable from that of the standard but showed significantly slower absorption (peak times of 3.6 ± 1.1 h vs 1.3 ± 0.8 h) and lower peak plasma concentrations (16.8 ± 4.7 mg/l/l g aminoph. dose vs 21.1 ± 4.2 mg/l/l g aminoph. dose). Projections of plasma concentrations upon multiple dosing were made from single dose data: the dosage interval (every 12 h) concentration ratio which reflects both the frequency of dosing and the entry of the drug into and removal from the body was 1.8 vs 3.1.

AB - Absorption of theophylline from one commercial product labelled as aminophylline systained release was compared to the absorption from an oral solution of aminophylline in a single-dose bioavailability study. Aminomal-R tablets had a bioavailability (101.2 ± 19) statistically indistinguishable from that of the standard but showed significantly slower absorption (peak times of 3.6 ± 1.1 h vs 1.3 ± 0.8 h) and lower peak plasma concentrations (16.8 ± 4.7 mg/l/l g aminoph. dose vs 21.1 ± 4.2 mg/l/l g aminoph. dose). Projections of plasma concentrations upon multiple dosing were made from single dose data: the dosage interval (every 12 h) concentration ratio which reflects both the frequency of dosing and the entry of the drug into and removal from the body was 1.8 vs 3.1.

UR - http://www.scopus.com/inward/record.url?scp=0022435234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022435234&partnerID=8YFLogxK

M3 - Articolo

VL - 76

SP - 641

EP - 645

JO - Minerva Medicolegale e Archivio di Antropologia Criminale

JF - Minerva Medicolegale e Archivio di Antropologia Criminale

SN - 0026-4806

IS - 13

ER -